₹3,500.00 Original price was: ₹3,500.00.₹3,199.00Current price is: ₹3,199.00.
The Pneumocystis Carinii (now called Pneumocystis jirovecii) Detection Test is used to diagnose Pneumocystis pneumonia (PCP), a serious fungal lung infection primarily affecting people with weakened immune systems (e.g., HIV/AIDS, organ transplant patients, cancer patients on chemotherapy).
โ
Detect Pneumocystis jirovecii infection in suspected PCP cases
โ
Diagnose lung infections in immunocompromised patients
โ
Confirm the presence of the fungus in respiratory samples
โ
Monitor at-risk individuals for early detection of PCP
| Test Type | Method | Sample Required | Purpose |
|---|---|---|---|
| PCR (Polymerase Chain Reaction) | Detects Pneumocystis DNA | Sputum, BAL (bronchoalveolar lavage), lung tissue | Highly sensitive, detects even low fungal loads |
| Direct Fluorescent Antibody (DFA) Stain | Uses fluorescent antibodies to detect the fungus | BAL, sputum, lung tissue | Common method, requires experienced lab personnel |
| Giemsa or Silver Staining | Stains fungal cysts for microscopic examination | BAL, lung biopsy, sputum | Less sensitive than PCR |
| Beta-D-Glucan Test | Measures fungal cell wall components | Blood sample | Supports diagnosis but not specific to Pneumocystis |
| Culture (Rarely Used) | Pneumocystis cannot be grown in routine lab cultures | Not applicable | Not used for diagnosis |
๐น Induced Sputum โ Non-invasive but may have lower sensitivity
๐น Bronchoalveolar Lavage (BAL) โ Best sample from deep lung fluid (requires bronchoscopy)
๐น Lung Tissue Biopsy โ Used in severe or unclear cases
๐ PCR & DFA on BAL samples are the most accurate diagnostic methods.
| Test Result | Interpretation |
|---|---|
| Positive PCR/DFA | Pneumocystis jirovecii detected โ PCP infection likely |
| Negative PCR/DFA | No fungus detected โ PCP unlikely (but clinical symptoms should be considered) |
| High Beta-D-Glucan | Suggests fungal infection (not specific for PCP) |
๐ A positive test, especially in an immunocompromised patient, strongly suggests PCP.
โ ๏ธ Progressive breathing problems, worsening over days to weeks:
โ Dry cough (no mucus)
โ Fever
โ Shortness of breath (worse with exertion)
โ Fatigue
โ Chest pain
๐น HIV/AIDS Patients โ CD4 count <200 cells/ยตL (most at risk)
๐น Organ Transplant Recipients โ On immunosuppressive drugs
๐น Cancer & Chemotherapy Patients โ Weakened immune system
๐น Patients on Long-Term Corticosteroids or Biologic Drugs โ e.g., for autoimmune diseases
๐น Severely Malnourished Individuals
๐ Treatment for PCP:
โ First-line therapy: Trimethoprim-Sulfamethoxazole (TMP-SMX, Bactrim)
โ Alternatives: Pentamidine, Atovaquone, Clindamycin + Primaquine (for sulfa allergies)
โ Severe cases: May require steroids (prednisone) to prevent lung inflammation
๐ PCP Prevention (Prophylaxis) for High-Risk Individuals:
โ TMP-SMX (Bactrim) prophylaxis if CD4 <200 in HIV/AIDS patients
โ Regular screening & early detection for transplant and chemotherapy patients